Lumexa Imaging Holdings, Inc. (LMRI) stock
LMRINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.01−0.62 (-4.24%)
Close on Nov 18, 2026Market cap $1.35BP/E –Yield –
Lumexa Imaging operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $28.11M | +1.6% |
| Q2 FY2026 | Jun 30, 2026 | $23.04M | -9.8% |
| Q1 FY2026 | Mar 31, 2026 | $19.41M | – |
| Q3 FY2025 | Sep 30, 2025 | $30.34M | – |
| Q2 FY2025 | Jun 30, 2025 | $27.68M | – |
| Q1 FY2025 | Mar 31, 2025 | $25.54M | – |
See a number that looks wrong?